Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Webb

Showing results (381-390 of 389) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 389 results.
Immunity|September 10, 2013
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanismJames M Murphy, Peter E Czabotar, Joanne M Hildebrand, et al.
Cell Death and Differentiation|July 13, 2019
Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancerPaul M Nguyen, Laura F Dagley, Adele Preaudet, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Science Translational Medicine|April 1, 2016
Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activationSeth L Masters, Vasiliki Lagou, Isabelle Jéru, et al.
Nature Immunology|December 12, 2023
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Nature Immunology|May 24, 2016
CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Science (New York, N.Y.)|December 21, 2019
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1Jérôme Le Nours, Nicholas A Gherardin, Sri H Ramarathinam, et al.
Molecular Cell|May 21, 2021
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J Hogg, Olga Motorna, Leonie A Cluse, et al.
Pageof 39

Showing results (381-390 of 389) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 389 results.
Immunity|September 10, 2013
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanismJames M Murphy, Peter E Czabotar, Joanne M Hildebrand, et al.
Cell Death and Differentiation|July 13, 2019
Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancerPaul M Nguyen, Laura F Dagley, Adele Preaudet, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Science Translational Medicine|April 1, 2016
Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activationSeth L Masters, Vasiliki Lagou, Isabelle Jéru, et al.
Nature Immunology|December 12, 2023
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Nature Immunology|May 24, 2016
CIS is a potent checkpoint in NK cell-mediated tumor immunityRebecca B Delconte, Tatiana B Kolesnik, Laura F Dagley, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Science (New York, N.Y.)|December 21, 2019
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1Jérôme Le Nours, Nicholas A Gherardin, Sri H Ramarathinam, et al.
Molecular Cell|May 21, 2021
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J Hogg, Olga Motorna, Leonie A Cluse, et al.
Pageof 39